CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
This Quarter Return
+2.44%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$90.4M
AUM Growth
+$90.4M
(-1.9%)
Cap. Flow
+$14.2M
Cap. Flow
% of AUM
15.67%
Top 10 Holdings %
Top 10 Hldgs %
94.64%
Holding
31
New
7
Increased
6
Reduced
7
Closed
6
Top Buys
| 1 |
MEI Pharma
MEIP
|
$17.3M |
| 2 |
Alerian MLP ETF
AMLP
|
$4.23M |
| 3 |
Marker Therapeutics
MRKR
|
$798K |
| 4 |
Investcorp Credit Management BDC
ICMB
|
$698K |
| 5 |
Kura Oncology
KURA
|
$299K |
Top Sells
| 1 |
AGRX
Agile Therapeutics, Inc
AGRX
|
$4.66M |
| 2 |
SCYNEXIS
SCYX
|
$3.14M |
| 3 |
FS KKR Capital
FSK
|
$508K |
| 4 |
AB InBev
BUD
|
$486K |
| 5 |
Barings BDC
BBDC
|
$259K |
Sector Composition
| 1 | Healthcare | 69.72% |
| 2 | Financials | 11.01% |
| 3 | Real Estate | 1.66% |
| 4 | Industrials | 1.06% |
| 5 | Utilities | 1.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AB InBev
BUD
$122B
| – | – | -4,425 | Closed | -$486K |
|
|
27
FS KKR Capital
FSK
$5.11B
| – | – | -70,115 | Closed | -$508K |
|
28
Madrigal Pharmaceuticals
MDGL
$9.76B
| – | – | -1,999 | Closed | -$233K |
|
29
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
|
AGRX
30
DELISTED
Agile Therapeutics, Inc
AGRX
| – | – | -1,814,949 | Closed | -$4.66M |
|
|
DRNA
31
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – | -13,074 | Closed | -$125K |
|